Your browser doesn't support javascript.
loading
Generation of an immunodeficient mouse model of tcirg1-deficient autosomal recessive osteopetrosis.
Palagano, Eleonora; Muggeo, Sharon; Crisafulli, Laura; Tourkova, Irina L; Strina, Dario; Mantero, Stefano; Fontana, Elena; Locatelli, Silvia L; Monari, Marta; Morenghi, Emanuela; Carlo-Stella, Carmelo; Barnett, John B; Blair, Harry C; Vezzoni, Paolo; Villa, Anna; Sobacchi, Cristina; Ficara, Francesca.
Afiliación
  • Palagano E; CNR-IRGB, Milan Unit, via Fantoli 16/15, 20138 Milan, Italy.
  • Muggeo S; Humanitas Clinical and Research Center IRCCS, via Manzoni 56, 20089 Rozzano, MI, Italy.
  • Crisafulli L; CNR-IRGB, Milan Unit, via Fantoli 16/15, 20138 Milan, Italy.
  • Tourkova IL; Humanitas Clinical and Research Center IRCCS, via Manzoni 56, 20089 Rozzano, MI, Italy.
  • Strina D; CNR-IRGB, Milan Unit, via Fantoli 16/15, 20138 Milan, Italy.
  • Mantero S; Humanitas Clinical and Research Center IRCCS, via Manzoni 56, 20089 Rozzano, MI, Italy.
  • Fontana E; Veteran's Affairs Medical Center and Department of Pathology, University of Pittsburgh, 4200 Fifth Avenue, Pittsburgh, PA 15260, USA.
  • Locatelli SL; CNR-IRGB, Milan Unit, via Fantoli 16/15, 20138 Milan, Italy.
  • Monari M; Humanitas Clinical and Research Center IRCCS, via Manzoni 56, 20089 Rozzano, MI, Italy.
  • Morenghi E; CNR-IRGB, Milan Unit, via Fantoli 16/15, 20138 Milan, Italy.
  • Carlo-Stella C; Humanitas Clinical and Research Center IRCCS, via Manzoni 56, 20089 Rozzano, MI, Italy.
  • Barnett JB; CNR-IRGB, Milan Unit, via Fantoli 16/15, 20138 Milan, Italy.
  • Blair HC; Humanitas Clinical and Research Center IRCCS, via Manzoni 56, 20089 Rozzano, MI, Italy.
  • Vezzoni P; Department of Oncology and Hematology, Humanitas Clinical and Research Center IRCCS, via Manzoni 56, 20089 Rozzano, MI, Italy.
  • Villa A; Clinical Investigation Laboratory, Humanitas Clinical and Research Center IRCCS, via Manzoni 56, 20089 Rozzano, MI, Italy.
  • Sobacchi C; Biostatistics Unit, Humanitas University, Rozzano, MI, Italy.
  • Ficara F; Department of Oncology and Hematology, Humanitas Clinical and Research Center IRCCS, via Manzoni 56, 20089 Rozzano, MI, Italy.
Bone Rep ; 12: 100242, 2020 Jun.
Article en En | MEDLINE | ID: mdl-31938717
BACKGROUND: Autosomal recessive osteopetrosis is a rare skeletal disorder with increased bone density due to a failure in osteoclast bone resorption. In most cases, the defect is cell-autonomous, and >50% of patients bear mutations in the TCIRG1 gene, encoding for a subunit of the vacuolar proton pump essential for osteoclast resorptive activity. The only cure is hematopoietic stem cell transplantation, which corrects the bone pathology by allowing the formation of donor-derived functional osteoclasts. Therapeutic approaches using patient-derived cells corrected ex vivo through viral transduction or gene editing can be considered, but to date functional rescue cannot be demonstrated in vivo because a relevant animal model for xenotransplant is missing. METHODS: We generated a new mouse model, which we named NSG oc/oc, presenting severe autosomal recessive osteopetrosis owing to the Tcirg1 oc mutation, and profound immunodeficiency caused by the NSG background. We performed neonatal murine bone marrow transplantation and xenotransplantation with human CD34+ cells. RESULTS: We demonstrated that neonatal murine bone marrow transplantation rescued NSG oc/oc mice, in line with previous findings in the oc/oc parental strain and with evidence from clinical practice in humans. Importantly, we also demonstrated human cell chimerism in the bone marrow of NSG oc/oc mice transplanted with human CD34+ cells. The severity and rapid progression of the disease in the mouse model prevented amelioration of the bone pathology; nevertheless, we cannot completely exclude that minor early modifications of the bone tissue might have occurred. CONCLUSION: Our work paves the way to generating an improved xenograft model for in vivo evaluation of functional rescue of patient-derived corrected cells. Further refinement of the newly generated mouse model will allow capitalizing on it for an optimized exploitation in the path to novel cell therapies.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Bone Rep Año: 2020 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Bone Rep Año: 2020 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Estados Unidos